Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Single Cord Blood Transplantation Combined With An HLA Mismatched Third Party Donor For High-Risk Hematological Patients With HIV Infection

Mi Kwon, MD, Jurgen H Kuball, MD, PhD, Pauline Ellerbroek, MD, PhD, Pascual Balsalobre, MSc, David Serrano, MD, Ismael Buno, PhD, Jorge Gayoso, MD, Koen van Besien, MD, PhD, Lawrence D. Petz, MD, Jose Luis Diez-Martin, MD, PhD, Annemarie Wensing, MD, PhD

Blood (2013) 122 (21): 3401.

https://doi.org/10.1182/blood.V122.21.3401.3401

Published: 2013

Journal Articles

Thiotepa-Based Vs TBI-Based Myeloablative Conditioning Prior To Allogeneic Stem Cell Transplantation (HSCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1): A Retrospective Analysis From The ALWP Of The EBMT

Sandra Eder, MD, Myriam Labopin, MD, William Arcese, MD, Reuven Or, MD, Ignazio Majolino, Andrea Bacigalupo, MD, Gennaro de Rosa, Liisa Volin, Dietrich Beelen, MD, Hendrik Veelken, MD PhD, Nicolaas PM Schaap, MD, PhD, Jurgen H Kuball, MD, PhD, Jan Cornelissen, MD, PhD, Arnon Nagler, MD, MSc, Mohamad Mohty, MD, PhD

Blood (2013) 122 (21): 2123.

https://doi.org/10.1182/blood.V122.21.2123.2123

Published: 2013

Journal Articles

Feasibility Of αβT- Cell Depleted Allogeneic Stem Cell Transplantations From Matched Related and Unrelated Donor Grafts and Engraftment In Patients With Poor Risk Leukemia

Liane te Boome, MD, Lotte van der Wagen, MD., Kasper Westinga, Ineke Slaper-Cortenbach, PhD, Jurgen H Kuball, MD, PhD

Blood (2013) 122 (21): 2063.

https://doi.org/10.1182/blood.V122.21.2063.2063

Published: 2013

Journal Articles

Conditioning Intensity In Middle Aged Patients With AML In CR1. No Advantage For Myeloablative Regimens Irrespective Of The Risk Group. An Observational Analysis By The Acute Leukemia Working Party Of The EBMT

Blood (2013) 122 (21): 542.

https://doi.org/10.1182/blood.V122.21.542.542

Published: 2013

Journal Articles

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT.

Moshe Yeshurun, MD, Myriam Labopin, Didier Blaise, MD, Jan Cornelissen, MD PhD, Henrik Sengeloev, MD, PhD, Lars Vindelov, MD, Jurgen H Kuball, MD, PhD, Patrice Chevallier, MD, PhD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2012) 120 (21): 3098.

https://doi.org/10.1182/blood.V120.21.3098.3098

Published: 2012

Journal Articles

Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Human Plasma and Platelet Lysate - a Phase I/II Study

Liane CJ te Boome, MD, Cristina M Mansilla, Caroline A Lindemans, MD, PhD, Lotte E Van der Wagen, MD, Marloes Cuijpers, MD, Ineke Slaper-Cortenbach, PhD, Henk Rozemuller, PhD, Eefke J Petersen, MD, PhD, Eric Spierings, PhD, Marc Bierings, Jaap J Boelens, MD, PhD, Nico Wulffraat, MD, PhD, Jurgen H Kuball, MD, PhD

Blood (2012) 120 (21): 736.

https://doi.org/10.1182/blood.V120.21.736.736

Published: 2012

NARROW

Single Cord Blood Transplantation Combined With An HLA Mismatched Third Party Donor For High-Risk Hematological Patients With HIV Infection

Thiotepa-Based Vs TBI-Based Myeloablative Conditioning Prior To Allogeneic Stem Cell Transplantation (HSCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1): A Retrospective Analysis From The ALWP Of The EBMT

Feasibility Of αβT- Cell Depleted Allogeneic Stem Cell Transplantations From Matched Related and Unrelated Donor Grafts and Engraftment In Patients With Poor Risk Leukemia

Conditioning Intensity In Middle Aged Patients With AML In CR1. No Advantage For Myeloablative Regimens Irrespective Of The Risk Group. An Observational Analysis By The Acute Leukemia Working Party Of The EBMT

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT.

Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Human Plasma and Platelet Lysate - a Phase I/II Study

Email alerts

ASH Publications

American Society of Hematology

Single Cord Blood Transplantation Combined With An HLA Mismatched Third Party Donor For High-Risk Hematological Patients With HIV Infection

Thiotepa-Based Vs TBI-Based Myeloablative Conditioning Prior To Allogeneic Stem Cell Transplantation (HSCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1): A Retrospective Analysis From The ALWP Of The EBMT

Feasibility Of αβT- Cell Depleted Allogeneic Stem Cell Transplantations From Matched Related and Unrelated Donor Grafts and Engraftment In Patients With Poor Risk Leukemia

Conditioning Intensity In Middle Aged Patients With AML In CR1. No Advantage For Myeloablative Regimens Irrespective Of The Risk Group. An Observational Analysis By The Acute Leukemia Working Party Of The EBMT

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT.

Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Human Plasma and Platelet Lysate - a Phase I/II Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only